Kelajakdagi narxning foydaga nisbati: Cerevel Corp (CERE)

Cerevel Therapeutics, Inc. (CERE) brendining ramzi va logotipi

GURU.Markets platformasida Cerevel Therapeutics (CERE) kompaniyasining kelajakdagi P/E koeffitsiyenti o'zgarishini baholagach, biz 0.00 ushbu metrikaning eng so'nggi qiymatini aks ettirishini aniqladik. Narxlarning bunday harakati AbbVie sog'liqni saqlash giganti tomonidan Cerevel Therapeutics (CERE) kompaniyasini sotib olish muvaffaqiyatini tasdiqlaydi, bu esa uning nevrologik dori vositalarining shaffofligi bilan bog'liq. Biroq, geosiyosiy mojarolar va sanksiyalar hozirda xalqaro tadqiqotlar hamda komponentlar logistikasiga to'sqinlik qilmoqda. Shu bilan birga, bozor baholashida shizofreniya davolash vositalarining o'rta muddatli istiqbolda ishga tushirilishi kutilgan holda, aktivlar sinergiyasi allaqachon hisobga olingan.

CERE - Cerevel Therapeutics Inc Prognoz qilingan narx-foyda nisbati 04.07.2022 - 10.08.2024 oraligʻida

cerevel.com (CERE) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning umumiy tahlili:Cerevel CERE
Cerevel Therapeutics brendining mahsuloti

Prognoz qilinadigan P/E koeffitsiyenti biznesning joriy bozor qiymatini kutilayotgan foyda bilan bog'laydi va kelajakdagi pul oqimi uchun to'langan premiumni baholash imkonini beradi. Cerevel Therapeutics (CERE) kompaniyasining prognoz qilinadigan narx-foyda koeffitsiyentini tahlil qilish orqali investor kapital qiymati va o'sish potentsiali o'rtasidagi muvozanatni aniqlaydi, bu esa Cerevel Therapeutics (CERE) uchun neyrodegenerativ kasalliklar terapiyasi bo'yicha noyob patentlar va kuchli R&D moliyalashtirishi bilan ta'minlanadi.

Toʻgʻridan-toʻgʻri raqobatchilar

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|ATHA: Prognoz qilingan narxning foydaga nisbati|ADXN (Addex Therapeutics, Ltd.) - Narxning kelajakdagi foydaga nisbati|Alzamend Neuro Inc. (ALZN) - Kelajakdagi narxning foydaga nisbati|Cyclerion - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati protagenic.com|Pasithea Therapeutics - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati CRGT (Cortigent, Inc.)|Avenue Therapeutics - Narxning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Brainstorm Cell BCLI|Forvard P/E multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forvard P/E multiplikatori|eliemtx.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Intra-Cellular Therapies (ITCI) - Kelajakdagi narxning foydaga nisbati|LBPH (Longboard) - Kelajakdagi narxning foydaga nisbati|MRNS (marinuspharma.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati NKGen Biotech NKGN|Kelajakdagi narxning foydaga nisbati NeuroBo Pharma (NRBO)|Kapitalizatsiyaning kelajakdagi foydaga nisbati SAGE|Synaptogenix, Inc. - Prognoz qilingan narxning foydaga nisbati|TRVN: Narxning kelajakdagi foydaga nisbati|VIGL - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori WENA (Anew Medical, Inc.)